The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

BACKGROUND: There is limited evidence for the effectiveness of daclatasvir in patients whose hepatitis C threatens their life expectancy. The Named Patient Program in Europe included patients with advanced chronic hepatitis C, a life expectancy of less than 12 months and no other treatment options....

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Jim, Weis, Nina, Hofer, Harald, Irving, William, Weiland, Ola, Giostra, Emiliano, Pascasio, Juan Manuel, Castells, Lluis, Prieto, Martin, Postema, Roelien, Lefevre, Cinira, Evans, David, Bucher, Heiner C., Calleja, Jose Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219681/
https://www.ncbi.nlm.nih.gov/pubmed/28061762
http://dx.doi.org/10.1186/s12879-016-2106-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219681/
https://www.ncbi.nlm.nih.gov/pubmed/28061762
http://dx.doi.org/10.1186/s12879-016-2106-x

Ejemplares similares